Form D · Biotechnology
BeyondSpring Inc.
New York, NY · CIK 0001677940
Offering snapshot reported Mar 21, 2017 · SEC filing
- Reported sold
- $7.22M Offering amount: $7.22M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 14, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2017 | Initial | $7,221,001 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $505K
- Finders' fees
- $0
- Form D file number
- 021-283016
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Mar 21, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard A. Brand | Executive |
| Nanxing He | Director |
| Lan Huang | Director, Executive |
| Matthew Kirkby | Director |
| Mulong Liu | Director |
| G. Kenneth Lloyd | Executive |
| Ramon Mohanlal | Executive |
| Gordon L. Schooley | Executive |
| Quanqi Song | Director |
| Yanbin Xie | Director |
| Christine Y. Zhao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
28 Liberty Street, 39th Floor
New York, NY, 10005
New York, NY, 10005